Symbols / YDES Stock $5.46 +4.10% YD Bio Ltd
YDES (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
Ratings
Current target
$5.46
Low
—
High
—
Mean
—
- symbol__ Stock Quote Price and Forecast - CNN Sat, 30 Aug 2025 19
- [Form 3/A] YD Bio Ltd Amended Initial Statement of Beneficial Ownership - Stock Titan Mon, 20 Apr 2026 15
- How does macroeconomics affect YD Bio (YDES) Stock | Price at $5.97, Down 4.57% - Popular Trader Picks - Cổng thông tin điện tử tỉnh Tây Ninh Mon, 13 Apr 2026 07
- YDES Stock Price and Chart — NASDAQ:YDES - TradingView Fri, 29 Aug 2025 14
- YD Bio (YDES) Stock Forecast and Price Target 2026 - MarketBeat Wed, 24 Dec 2025 10
- Is YD Bio (YDES) stock reacting to key levels (Edges Lower) 2026-04-20 - Reversal Picks - Cổng thông tin điện tử tỉnh Lào Cai Mon, 20 Apr 2026 09
- Director at YD Bio (YDES) receives $60K RSU equity award - Stock Titan hu, 02 Apr 2026 07
- YD Bio (YDES) Stock: Solid Choice? (Nudges Down) 2026-04-16 - Turnaround Stocks - Cổng thông tin điện tử tỉnh Tây Ninh hu, 16 Apr 2026 13
- YD Bio (YDES) director receives $60,000 RSU grant and 2,081 shares - Stock Titan hu, 02 Apr 2026 07
- Is YD Bio (YDES) Stock Showing Strength | Price at $6.61, Down 5.30% - Bearish Pattern - Xã Vĩnh Công Wed, 08 Apr 2026 07
- Cancer test platform goes live in 44 states, D.C. and Guam - Stock Titan ue, 31 Mar 2026 07
- Director Chang Kochi logs initial insider status at YD Bio Ltd (YDES) - Stock Titan hu, 02 Apr 2026 07
- YD Bio (NASDAQ: YDES) director Lu Shao-Ta files initial Form 3 - Stock Titan hu, 02 Apr 2026 07
- YDES SEC Filings - YD Bio Ltd 10-K, 10-Q, 8-K Forms - Stock Titan Sat, 04 Apr 2026 08
- YD Bio (YDES) director files Form 3 with no share activity - Stock Titan Mon, 30 Mar 2026 07
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Revenue |
|
0.51
+45.76%
|
0.35
|
| Operating Revenue |
|
0.51
+45.76%
|
0.35
|
| Cost Of Revenue |
|
0.36
+80.49%
|
0.20
|
| Reconciled Cost Of Revenue |
|
0.36
+80.49%
|
0.20
|
| Gross Profit |
|
0.16
+1.25%
|
0.15
|
| Operating Expense |
|
1.62
+907.58%
|
0.16
|
| Research And Development |
|
0.49
|
0.00
|
| Selling General And Administration |
|
1.13
+601.56%
|
0.16
|
| Selling And Marketing Expense |
|
0.00
-73.88%
|
0.01
|
| General And Administrative Expense |
|
1.12
+634.62%
|
0.15
|
| Other Gand A |
|
1.12
+634.62%
|
0.15
|
| Total Expenses |
|
1.97
+452.22%
|
0.36
|
| Operating Income |
|
-1.46
-20451.19%
|
-0.01
|
| Total Operating Income As Reported |
|
-1.46
-14746.45%
|
-0.01
|
| EBITDA |
|
-1.28
-5858.21%
|
0.02
|
| Normalized EBITDA |
|
-1.28
-5230.58%
|
0.02
|
| Reconciled Depreciation |
|
0.10
+4171.41%
|
0.00
|
| EBIT |
|
-1.39
-7100.64%
|
0.02
|
| Total Unusual Items |
|
0.00
+118.05%
|
-0.00
|
| Total Unusual Items Excluding Goodwill |
|
0.00
+118.05%
|
-0.00
|
| Special Income Charges |
|
0.00
+118.05%
|
-0.00
|
| Write Off |
|
-0.00
-118.05%
|
0.00
|
| Net Income |
|
-1.41
-10509.73%
|
0.01
|
| Pretax Income |
|
-1.39
-7955.41%
|
0.02
|
| Net Non Operating Interest Income Expense |
|
0.01
+695.25%
|
-0.00
|
| Interest Expense Non Operating |
|
0.00
-63.99%
|
0.00
|
| Net Interest Income |
|
0.01
+695.25%
|
-0.00
|
| Interest Expense |
|
0.00
-63.99%
|
0.00
|
| Interest Income Non Operating |
|
0.01
+3971.72%
|
0.00
|
| Interest Income |
|
0.01
+3971.72%
|
0.00
|
| Other Income Expense |
|
0.06
+143.83%
|
0.03
|
| Other Non Operating Income Expenses |
|
0.06
+119.46%
|
0.03
|
| Tax Provision |
|
0.03
+513.20%
|
0.00
|
| Tax Rate For Calcs |
|
0.00
-13.69%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
+115.58%
|
-0.00
|
| Net Income Including Noncontrolling Interests |
|
-1.41
-10509.73%
|
0.01
|
| Net Income From Continuing Operation Net Minority Interest |
|
-1.41
-10509.73%
|
0.01
|
| Net Income From Continuing And Discontinued Operation |
|
-1.41
-10509.73%
|
0.01
|
| Net Income Continuous Operations |
|
-1.41
-10509.73%
|
0.01
|
| Normalized Income |
|
-1.41
-9117.37%
|
0.02
|
| Net Income Common Stockholders |
|
-1.41
-10509.73%
|
0.01
|
| Diluted EPS |
|
—
|
0.00
|
| Basic EPS |
|
—
|
0.00
|
| Basic Average Shares |
|
—
|
70.10
|
| Diluted Average Shares |
|
—
|
70.10
|
| Diluted NI Availto Com Stockholders |
|
-1.41
-10509.73%
|
0.01
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Assets |
|
6.86
+2036.98%
|
0.32
|
| Current Assets |
|
3.47
+1176.25%
|
0.27
|
| Cash Cash Equivalents And Short Term Investments |
|
3.13
+3496.29%
|
0.09
|
| Cash And Cash Equivalents |
|
3.13
+3496.29%
|
0.09
|
| Receivables |
|
0.26
+166.98%
|
0.10
|
| Accounts Receivable |
|
0.09
-11.80%
|
0.10
|
| Gross Accounts Receivable |
|
0.09
-12.07%
|
0.10
|
| Allowance For Doubtful Accounts Receivable |
|
-0.00
+18.94%
|
-0.00
|
| Taxes Receivable |
|
0.16
+59558.05%
|
0.00
|
| Inventory |
|
0.04
-46.21%
|
0.07
|
| Finished Goods |
|
0.04
-46.21%
|
0.07
|
| Prepaid Assets |
|
0.04
+111.18%
|
0.02
|
| Total Non Current Assets |
|
3.40
+6762.96%
|
0.05
|
| Net PPE |
|
0.09
+515.71%
|
0.01
|
| Gross PPE |
|
0.11
+374.11%
|
0.02
|
| Accumulated Depreciation |
|
-0.02
-119.29%
|
-0.01
|
| Properties |
|
0.00
|
0.00
|
| Buildings And Improvements |
|
0.02
+80.69%
|
0.01
|
| Machinery Furniture Equipment |
|
0.08
+795.17%
|
0.01
|
| Goodwill And Other Intangible Assets |
|
2.68
|
0.00
|
| Other Intangible Assets |
|
2.68
|
—
|
| Investments And Advances |
|
0.00
-100.00%
|
0.01
|
| Non Current Deferred Assets |
|
0.63
+2457.43%
|
0.02
|
| Non Current Deferred Taxes Assets |
|
0.00
-100.00%
|
0.02
|
| Total Liabilities Net Minority Interest |
|
0.27
-8.13%
|
0.30
|
| Current Liabilities |
|
0.26
-11.79%
|
0.30
|
| Payables And Accrued Expenses |
|
0.25
-1.64%
|
0.25
|
| Payables |
|
0.06
-73.09%
|
0.24
|
| Accounts Payable |
|
0.03
+48.77%
|
0.02
|
| Current Accrued Expenses |
|
0.18
+1291.85%
|
0.01
|
| Total Tax Payable |
|
—
|
0.00
|
| Current Debt And Capital Lease Obligation |
|
0.02
-64.54%
|
0.05
|
| Current Debt |
|
0.00
-99.15%
|
0.03
|
| Other Current Borrowings |
|
—
|
0.03
|
| Current Capital Lease Obligation |
|
0.02
+25.07%
|
0.01
|
| Current Deferred Liabilities |
|
—
|
0.00
|
| Current Deferred Revenue |
|
—
|
0.00
|
| Total Non Current Liabilities Net Minority Interest |
|
0.01
|
0.00
|
| Long Term Debt And Capital Lease Obligation |
|
0.01
|
0.00
|
| Long Term Capital Lease Obligation |
|
0.01
|
0.00
|
| Non Current Deferred Liabilities |
|
0.00
|
—
|
| Non Current Deferred Taxes Liabilities |
|
0.00
|
—
|
| Other Non Current Liabilities |
|
0.00
|
—
|
| Stockholders Equity |
|
6.59
+28560.72%
|
0.02
|
| Common Stock Equity |
|
6.59
+28560.72%
|
0.02
|
| Capital Stock |
|
0.14
+37.05%
|
0.11
|
| Common Stock |
|
0.14
+37.05%
|
0.11
|
| Share Issued |
|
70.10
+0.00%
|
70.10
|
| Ordinary Shares Number |
|
70.10
+0.00%
|
70.10
|
| Additional Paid In Capital |
|
8.33
+2057.15%
|
0.39
|
| Retained Earnings |
|
-1.93
-273.83%
|
-0.52
|
| Gains Losses Not Affecting Retained Earnings |
|
0.05
-4.53%
|
0.05
|
| Total Equity Gross Minority Interest |
|
6.59
+28560.72%
|
0.02
|
| Total Capitalization |
|
6.59
+28560.72%
|
0.02
|
| Working Capital |
|
3.20
+12196.41%
|
-0.03
|
| Invested Capital |
|
6.59
+11399.20%
|
0.06
|
| Total Debt |
|
0.02
-52.59%
|
0.05
|
| Capital Lease Obligations |
|
0.02
+67.95%
|
0.01
|
| Net Tangible Assets |
|
3.91
+16905.35%
|
0.02
|
| Tangible Book Value |
|
3.91
+16905.35%
|
0.02
|
| Available For Sale Securities |
|
—
|
0.01
|
| Current Notes Payable |
|
0.00
|
0.00
|
| Dueto Related Parties Current |
|
0.04
-82.93%
|
0.22
|
| Investmentin Financial Assets |
|
0.00
-100.00%
|
0.01
|
| Notes Receivable |
|
0.02
|
0.00
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Cash Flow |
|
-1.84
-3200.25%
|
-0.06
|
| Cash Flow From Continuing Operating Activities |
|
-1.84
-3200.25%
|
-0.06
|
| Net Income From Continuing Operations |
|
-1.41
-10509.73%
|
0.01
|
| Depreciation Amortization Depletion |
|
0.10
+4171.41%
|
0.00
|
| Depreciation |
|
0.01
+315.95%
|
0.00
|
| Amortization Cash Flow |
|
0.09
|
0.00
|
| Depreciation And Amortization |
|
0.10
+4171.41%
|
0.00
|
| Amortization Of Intangibles |
|
0.09
|
0.00
|
| Other Non Cash Items |
|
0.01
-75.43%
|
0.05
|
| Asset Impairment Charge |
|
-0.00
-118.05%
|
0.00
|
| Deferred Tax |
|
0.03
+549.78%
|
0.00
|
| Deferred Income Tax |
|
0.03
+549.78%
|
0.00
|
| Operating Gains Losses |
|
—
|
0.00
|
| Gain Loss On Sale Of PPE |
|
0.00
-100.00%
|
0.00
|
| Change In Working Capital |
|
-0.57
-348.17%
|
-0.13
|
| Change In Receivables |
|
-0.01
+82.74%
|
-0.06
|
| Changes In Account Receivables |
|
0.01
+109.86%
|
-0.06
|
| Change In Inventory |
|
0.03
+193.28%
|
-0.03
|
| Change In Prepaid Assets |
|
-0.18
-3892.47%
|
0.00
|
| Change In Payables And Accrued Expense |
|
0.22
+2138.81%
|
0.01
|
| Change In Accrued Expense |
|
0.21
+4538.33%
|
0.00
|
| Change In Payable |
|
0.01
+89.13%
|
0.01
|
| Change In Account Payable |
|
0.01
+89.13%
|
0.01
|
| Change In Other Working Capital |
|
-0.61
|
—
|
| Change In Other Current Liabilities |
|
-0.01
+74.00%
|
-0.05
|
| Investing Cash Flow |
|
-2.90
-1000131.03%
|
-0.00
|
| Cash Flow From Continuing Investing Activities |
|
-2.90
-1000131.03%
|
-0.00
|
| Net PPE Purchase And Sale |
|
-0.07
-25732.41%
|
-0.00
|
| Purchase Of PPE |
|
-0.07
-25732.41%
|
-0.00
|
| Capital Expenditure |
|
-2.91
-1003691.03%
|
-0.00
|
| Net Investment Purchase And Sale |
|
0.01
|
0.00
|
| Sale Of Investment |
|
0.01
|
0.00
|
| Net Intangibles Purchase And Sale |
|
-2.84
|
0.00
|
| Purchase Of Intangibles |
|
-2.84
|
0.00
|
| Financing Cash Flow |
|
7.73
+6685.36%
|
0.11
|
| Cash Flow From Continuing Financing Activities |
|
7.73
+6685.36%
|
0.11
|
| Net Issuance Payments Of Debt |
|
-0.03
-1.13%
|
-0.03
|
| Repayment Of Debt |
|
-0.03
-1.13%
|
-0.03
|
| Long Term Debt Payments |
|
-0.03
-1.13%
|
-0.03
|
| Net Long Term Debt Issuance |
|
-0.03
-1.13%
|
-0.03
|
| Net Common Stock Issuance |
|
7.86
+14743.97%
|
0.05
|
| Net Other Financing Charges |
|
-0.10
-206.43%
|
0.09
|
| Changes In Cash |
|
2.99
+5060.78%
|
0.06
|
| Effect Of Exchange Rate Changes |
|
0.06
+5693.70%
|
-0.00
|
| Beginning Cash Position |
|
0.09
+188.96%
|
0.03
|
| End Cash Position |
|
3.13
+3496.29%
|
0.09
|
| Free Cash Flow |
|
-4.75
-8386.27%
|
-0.06
|
| Interest Paid Supplemental Data |
|
0.00
-63.99%
|
0.00
|
| Income Tax Paid Supplemental Data |
|
0.00
|
0.00
|
| Common Stock Issuance |
|
7.86
+14743.97%
|
0.05
|
| Issuance Of Capital Stock |
|
7.86
+14743.97%
|
0.05
|
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|